Colgate‑Palmolive India has ample room to grow in awareness, consumption, distribution and premiumisation, according to Nomura after a recent analyst meeting. The brokerage said the company is well‑placed to capture this opportunity.
The firm will focus on outpacing peers by balancing volume growth with price and mix. Category growth is expected to rise in the mid‑single digits, and price‑plus‑mix growth should also be in the mid‑single digits.
Nomura noted that Colgate‑Palmolive has accelerated premiumisation, but is stepping up advertising and promotion (A&P). This will limit operating profit margin (OPM) and lead to profit growth that is slightly lower than sales in the short term. The broker sees this as a sound strategy for steady, consistent growth.
India’s oral health awareness remains low compared to the incidence of dental issues, and systemic health and consumption habits affect the market. Toothpaste has reached universal penetration, yet there is still significant opportunity in distribution, consumption and premiumisation.
The toothpaste category covers 8.4 million retail outlets, while Colgate‑Palmolive India reaches 7.1 million outlets, representing 56% and 47% of the FMCG universe respectively.
On consumption, 45% of rural households do not brush daily, a drop from 55% in 2023. Urban consumers brushing twice a day rose to 24% from 20% in 2023.
Premium toothpaste accounts for only 19% of the category, whereas premiumisation in soaps and shampoos is 2‑to‑3 times higher. Colgate remains the most considered brand, at 90% versus 87% in 2024, and the most recalled, at 67% versus 64% in 2024.
The company is the most distributed brand, with 85% category reach and a total reach of 7.1 million outlets, up from 6.6 million in 2024. It also operates 1.7 million direct outlets.
Colgate‑Palmolive India has the widest portfolio, three times the size of the second player, thanks to superior technology and R&D.
The firm’s four‑pillar strategy includes driving night brushing in urban markets through its oral health movement, which has delivered over 1 million dental check‑ups. In rural markets, the “Bright Smiles, Bright Future” programme is growing 10% annually.
The company is accelerating premiumisation with science‑backed products. The sensitive category is growing 10 times faster than the broader category.
Advertising and promotion are being stepped up through tie‑ups with KBC, IPL and increased influencer marketing on social media. New product launches include Bluey and Harry Potter collections for kids, with an adults launch expected soon.
Other initiatives involve new packaging with vacuum pumps for e‑commerce and quick‑commerce, and a partnership with Bombay Shaving Company to grow Palmolive Bodywash via D2C and digital channels.
Nomura also noted that Colgate‑Palmolive can introduce new brands or products from the parent portfolio at the right time.
Nomura maintains a “Buy” rating with a target price of Rs 2,550. The brokerage expects sales and EBITDA to recover to double digits from the second quarter, supporting the stock.
The firm values the company at 42× P/E on June 2028F EPS and forecasts a 10.5% EPS CAGR over FY26‑29F. It also highlights key downside risks such as weak volumes and margins.